Orion completes acquisition of LegoChem Biosciences
Paul Lee
hoondork1977@alphabiz.co.kr | 2024-04-01 03:57:32
(Photo = Yonhap news)
[Alpha Biz=(Chicago) Reporter Paul Lee] Orion said it has become the largest shareholder after paying 548.5 billion won in stock prices to acquire a 25.73% stake in LegoChem Biosciences.
Orion participated in LegoChem Biosciences's third-party paid-in capital increase and was allocated 7,963,283 shares for 59,000 won. It purchased 1.4 million old shares at a base price of 56,186 won from its founder Kim Yong-joo and CEO Park Se-jin to secure a total of 9,363,283 shares.
It plans to develop new drugs through its affiliate LegoChem Biosciences and complete its business portfolio for the group's sustainable growth.
[ⓒ AlphaBIZ. 무단전재-재배포 금지]
많이 본 기사
- 1Korean Low-Cost Carriers Cut Routes as Oil Prices and Currency Surge Amid Middle East Tensions
- 2KakaoBank App Outage Occurred Twice Due to Misdiagnosed Cause, Lawmaker Raises Concerns
- 3Aekyung Chemical to Sell China Subsidiary After Halting Operations
- 4DB HiTek Minority Shareholders Urge Forced Disposal of Alleged Hidden Stake by Founder
- 5Samsung Electronics GOS Lawsuit Over Galaxy S22 Ends After Four Years with Court-Mediated Settlement
- 6Toss Removes “Han River Temperature” Feature After Backlash Over Insensitive Messaging